Macquarie Group LTD Harmony Biosciences Holdings, Inc. Transaction History

Macquarie Group LTD

  • $90.3 Billion
  • Q3 2024

A detailed history of Macquarie Group LTD transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 292,747 shares of HRMY stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
292,747
Previous 295,880 1.06%
Holding current value
$10.2 Million
Previous $8.93 Million 31.02%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$30.0 - $39.95 $93,990 - $125,163
-3,133 Reduced 1.06%
292,747 $11.7 Million
Q2 2024

Aug 09, 2024
SELL
$28.81 - $33.01 $115,989 - $132,898
-4,026 Reduced 1.34%
295,880 $8.93 Million
Q1 2024

May 14, 2024
SELL
$29.93 - $35.06 $8.25 Million - $9.66 Million
-275,646 Reduced 47.89%
299,906 $10.1 Million
Q4 2023

Feb 14, 2024
SELL
$19.2 - $33.78 $7.24 Million - $12.7 Million
-376,841 Reduced 39.57%
575,552 $18.6 Million
Q3 2023

Nov 14, 2023
BUY
$31.89 - $39.03 $1.62 Million - $1.99 Million
50,865 Added 5.64%
952,393 $31.2 Million
Q2 2023

Aug 14, 2023
BUY
$30.5 - $37.4 $2.22 Million - $2.72 Million
72,859 Added 8.79%
901,528 $31.7 Million
Q1 2023

May 15, 2023
BUY
$30.8 - $53.92 $3.9 Million - $6.82 Million
126,575 Added 18.03%
828,669 $27.1 Million
Q4 2022

Feb 21, 2023
BUY
$45.4 - $60.91 $1.87 Million - $2.51 Million
41,250 Added 6.24%
702,094 $38.7 Million
Q3 2022

Nov 14, 2022
BUY
$42.06 - $55.45 $1.29 Million - $1.7 Million
30,633 Added 4.86%
660,844 $29.3 Million
Q2 2022

Aug 15, 2022
BUY
$33.54 - $52.15 $7.54 Million - $11.7 Million
224,843 Added 55.47%
630,211 $30.7 Million
Q1 2022

May 16, 2022
BUY
$33.14 - $51.13 $13.4 Million - $20.7 Million
405,368 New
405,368 $19.7 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.05B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email